Intent is a data science company for the world’s leading online travel and commerce brands. Our Predictive Intelligence Platform uses patented technology to predict user behavior in real-time and identify the future value of every user. Over 450 innovative brands trust <intent> predictions to deliver personalized user experiences that maximize utility and ROI. The company is proud to work with partners like Priceline, Expedia, TripAdvisor, Hotels.com, Wotif, Skyscanner, Hotwire, ebookers, lastminute.com, Delta, AA, Lufthansa, Marriott, and Enterprise. To learn more, visit Intent.com.

Findability Sciences applies the power of big data, cognitive computing, and artificial intelligence (AI) in its core product: the award winning Findability Platform®. The Findability Platform makes use of its proprietary technologies to add context to data and incorporates self-learning capabilities to deliver turnkey solutions to major global corporations in the insurance, retail, manufacturing, financial services, trading, healthcare, and transportation industries. The Findability Platform’s unique framework makes it possible for business executives to achieve AI competency in just weeks with minimal expense and without dependence on data scientists. The Findability Platform: 1. Unifies structured, unstructured, internal and external data to maximize the value of data assets 2. Enables conversational computing to provide humanlike interactions through chatbots and virtual agents 3. Produces applicative insights that let marketing executives identify and cater to various consumer personas based on their personalities, needs, and values 4. Automatically generates predictions from diverse datasets to create leading indicators in areas such as raw material costs, finished goods pricing, risks of fraud in financial services, and maintenance needs more accurately than ever before possible A SoftBank Corp portfolio company, Findability Sciences is also an investor in both a joint venture with SoftBank and in a privately held predictive modeling technology company. Findability Sciences partners with leading technology providers and is part of the IBM Watson Partner Ecosystem. Headquartered outside Boston, MA, Findability Sciences serves its customers through offices in the United States, Japan, and India.

Lynx Analytics is a predictive analytics outlet run by quantitative marketing scientists and industry experienced data scientists. The company's focus on (Big) Data and (Big) Analytics industry challenges, coupled with our expert RnD team with 10+ years of Google and startup experience in optimizing algorithms and productizing predictive engines have yielded a unique and efficient analytics process. Furthermore, our teams' qualifications are worldwide, including Professors, PhD.s, MScs, and MBAs from Berkeley, Columbia, Corvinus, INSEAD, and NUS, as well as experience in managing analytical modeling teams at prestigious companies such as T-Mobile or GE Money. It is the combination of our insightful frameworks, product development capabilities, and these qualifications which are the true value of Lynx's proposition.

The best content to the right people. There is so much content. You've bought some, you've created some and there's much more online. The world doesn't need more content. It needs the best content to get to the right people. Filtered does that.

novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.

After more than forty years on Wall Street, stock market expert Marc Chaikin founded Chaikin Analytics, LLC in 2009 to deliver to deliver proven, institutional-quality stock analysis to professional money managers and self-directed investors.

NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trials globally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases.

At IKANGAI, we empower businesses to harness the power of artificial intelligence to deliver personalized and relevant experiences for their customers. As a comprehensive AI consulting firm, we specialize in ideation and advisory,, crafting forward-thinking strategies and concepts for enhanced customer interactions. With IKANGAI's help, enterprises can leverage AI-driven insights to optimize every touchpoint in the customer journey to ensure timely and optimised customer engagement. Our commitment is to provide businesses with the most advanced AI solutions for customer engagement, rooted in a culture of trust, innovation, and continuous feedback from our partners and clientele. We are a rapidly expanding, goal-oriented team with a relaxed approach, always eager to connect with individuals who share our vision. Reach out and explore the future of AI with us!